<?xml version="1.0" encoding="utf-8" ?>

<XML>
  <JOURNAL>   
    <YEAR>2024</YEAR>
    <VOL>25</VOL>
    <NO>3</NO>
    <MOSALSAL>100</MOSALSAL>
    <PAGE_NO>73</PAGE_NO>  
    <ARTICLES>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Radical Changes in Infertility Practice: It Is Coming Soon</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140242</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Infertility is a medical, personal, and public health problem in all human societies that affects about 15% of couples of reproductive ages, being the significant concern of patients, doctors, and health policymakers worldwide during the last decade. The spread of assisted reproductive technologies (ARTs) has facilitated the diagnosis and treatment of infertility in most countries; however, the total number of children born from IVF is less than 0.2% of the world&#39;s population, although 1-5% of neonates are conceived by ART in some countries. Recently, ARTs have been transformed in terms of variety and quality for their wider application in correction of gene defects, treatment of genetic diseases, and gene therapy along with genetic modifications in the livestock industry. The main incentive for the advancements was the relatively low efficiency of ART outcomes and the increasing need for their implementation in the treatment of infertility (1).&lt;br /&gt;
One of these areas of progress is the growing application of artificial intelligence (AI) in the clinical aspects of human reproduction and infertility through the integration of medicine and computer science using machine learning algorithms. Artificial intelligence has been utilized for nearly two decades in various fields of human reproduction, including diagnosis of infertility and prognosis of treatment outcomes in the form of chemical/ clinical pregnancies, live births, and repeated IVF failures. Moreover, the technology has been applicable in evaluation of ovarian reserve, ultrasound assessment of follicles growth in IVF cycle, determining endometrial quality, and its potential for embryo implantation, as well as sperm, egg, and embryo selection. Therefore, replacement of existing invasive methods with non-invasive ones based on artificial intelligence is not far from expected. In the field of male reproductive health, AI is being developed from Computer-Assisted Semen Analysis (CASA) systems to the applications evaluating environmental factors and lifestyle for predicting sperm quality. Furthermore, AI is perceived as a utilitarian alternative in diagnosing the causes of idiopathic infertility based on the biological and clinical symptoms of infertile couples (2).&lt;br /&gt;
In addition to the development and expansion of AI application among experts in the fields of fertility and infertility, its function in basic research and clinical practice serves as an ancillary and supportive mechanism in infertility treatment. In this context, another important aspect worthy of paramount attention is the very rapid expansion of AI among community, especially among infertile couples and recipients of ART services. In the past, people with different levels of knowledge and ability had limited access to scientific and medical databases. Their education mainly hinged upon public databases and commercial websites, which provided incomplete data or sometimes conflicting information. Their reliance on untrustworthy sources could jeopardize their health and result in adverse medical and economic consequences for both themselves and the healthcare system (3).&lt;br /&gt;
Infertile couples usually surf the net for quick access to fertility care information. For instance, A query for the term &quot;infertility&quot; on Google brings millions of results, many of which have not been verified for scientific and medical validity. Most of commercial websites with pseudo-scientific data use SEO techniques to improve their ranking in the top list of search results, occasionally deceiving the na&#239;ve users to sell their products or attract more customers. In fact, most people believe that the top search results are the best sources of information to address their needs, which is often not the case. However, search engines have gradually given way to chatbots, which are models of generative AI and large language models. Large language models (LLMs) are a class of deep learning architecture designed to recognize and produce human-like languages. Chatbots such as ChatGPT, Google Bard, or Claude are built on the transformer model, utilizing self-aware language processing for Natural Language Processing (NLP) and Reinforcement Learning (RL) to identify complex relationships between words. These multimodal generative AI systems have attracted considerable attention from mass media during the recent years (3, 4).&lt;br /&gt;
Quick access to information and ease of data gathering from chatbots, such as ChatGPT, are the main prompts for infertile couples to use chatbots for their inquiries rather than visiting IVF clinic staff and infertility treatment professionals. Chatbots can translate medical information in an easier way for the general public to deeply understand and improve their level of knowledge and information. Such preliminary knowledge would facilitate patients’ participation during the diagnosis and treatment procedure. In addition to maintaining anonymity and privacy, infertile couples feel more comfortable using digital tools like ChatGPT compared to receiving information from healthcare professionals. In addition, they find the exact answers to their most private questions that they may not feel convenient to share even with the closest family members (3).&lt;br /&gt;
The current limitation in using chatbots involves reliance on more familiar bots like ChatGPT. However, similar models such as Cloud, Microsoft Bing, and Google Bard are alternative options for addressing the needs of patients. Despite providing quick responses to patient requests, there is a possibility that chatbots are using data from unreliable sources, so that the consistency of responses may be affected during subsequent iterations (3). In one study, frequently asked questions (81 questions) about endometriosis were used to evaluate the accuracy of ChatGPT’s responses. An experienced gynecologist assigned a score from 1 to 4 for each answer provided by ChatGPT. In total, 91.4% of frequently asked questions were considered correct. ChatGPT had the highest accuracy in responses about symptoms and diagnosis (94.1%) and the lowest in responses on treatment (81.3%). In another study, the responses of three chatbots were ranked and averaged with the comments and opinions of 3 experienced gynecologists. Comparing the 3 chatbots, it was revealed that Bard had better average scores than ChatGPT or Cloud, and most of the chatbot’s responses were correct (5).&lt;br /&gt;
All in all, the development of AI and LLM will lead to fundamental changes in the field of reproduction and infertility, which will be as revolutionary as the invention of conventional IVF or ICSI. Currently, the role of the doctor and healthcare staff is to diagnose and choose the best treatment method based on consultation, physical examination, and the results of paraclinical tests. Consequently, the personalized plan would be tailored for each individual. However, due to limited knowledge in various aspects of couples’ lives including their behavioral, biological, and medical characteristics, the treatment method chosen by the doctor is not necessarily the best alternative. With the expansion of AI and LLM to evaluate couples&#39; fertility and addressing their needs regarding all lifestyle aspects and characteristics, the proposed treatment will be much more accurate and precise than the status quo of infertility diagnosis and treatment. The new technology would undoubtedly change the practice of infertility treatment in the clinics as well as the role of doctors and specialists. In the near future, it is expected that one couple may arrive at your IVF center requesting IUI, while others may seek TESE/ICSI/eSET, yet the next couple may request ICSI/PGT-SR, with the doctors refraining from intervening in couples’ decision for the requested treatment procedure. In this context, the diagnosis and selection of the best treatment method will be assigned to AI. From now on, we have to acknowledge that AI is a very powerful tool for the future since the technology continues to develop and advance in medical equipment and telemedicine, culminating in fundamental changes in treatment sector.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>169</FPAGE>
            <TPAGE>171</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mohammad Reza</Name>
<MidName>MR</MidName>
<Family>Sadeghi</Family>
<NameE> محمدرضا</NameE>
<MidNameE></MidNameE>
<FamilyE>صادقی</FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>sadeghi@avicenna.ac.ir</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>No Keyword</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140242.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Kushnir VA, Smith GD, Adashi EY. The future of IVF: the new normal in human reproduction. Reprod Sci. 2022;29(3):849-56.##Hanassab S, Abbara A, Yeung AC, Voliotis M, Tsaneva-Atanasova K, Kelsey TW, et al. The prospect of artificial intelligence to personalize assisted reproductive technology. NPJ Digit Med. 2024;7(1):55.##Beilby K, Hammarberg K. ChatGPT: a reliable fertility decision-making tool? Hum Reprod. 2024;39(3):443-47.##Brand&#227;o M, Mendes F, Martins M, Cardoso P, Macedo G, Mascarenhas T, et al. Revolutionizing women&#39;s health: a comprehensive review of artificial intelligence advancements in gynecology. J Clin Med. 2024;13(4):1061.##Oliveira JA, Eskandar K, Kar E, de Oliveira FR, Filho AL. Understanding AI&#39;s role in endometriosis patient education and evaluating its information and accuracy: systematic review. JMIR AI. 2024:3:e64593.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>The Influence of Artificial Light Exposure on Indigenous Populations: Exploring Its Impact on Menarcheal Age and Reproductive Function</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140233</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;The impact of artificial light exposure on human health has garnered significant attention in recent years. In particular, its effects on reproductive health have raised concerns. Given that the onset of menarche serves as a crucial indicator of reproductive maturity, understanding the implications of artificial light exposure becomes paramount. Age of menarche onset occurs relatively earlier in urban females than females raised in rural areas. Besides the decline in age of menarche onset, exposure to artificial light may contribute to impairment in reproductive hormones, particularly gonadotropins, by disrupting rhythms of reproductive hormones, modulating stress hormones and kisspeptin productions, and causing body weight changes. This drastic environmentally induced change may increase the proportion of teenage pregnancies, unfulfilled childhood dreams, depression, and ill-prepared marriages, thus creating a potential need for public health intervention. Due to limited studies and often lack of longitudinal data, a significant knowledge gap exists in unraveling the potential mechanism involved in alteration of these physiologic processes. The purpose of the current review was to elucidate the intricate interplay between environmental factors, cultural practices, and biological processes within indigenous communities. By meticulously examining the multifaceted influences of artificial light, including its prevalence and varying intensity based on geographical locations and light pollution levels, this study aimed to provide scholarly insights into the pathophysiologic mechanisms underlying the observed changes. The findings of this inquiry will also inform evidence-based strategies and interventions aimed at safeguarding the reproductive well-being of indigenous populations amidst the escalating challenges posed by artificial light exposure.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>171</FPAGE>
            <TPAGE>184</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mayowa</Name>
<MidName>MJ</MidName>
<Family>Adeniyi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, Federal University of Health Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, Federal University of Health Sciences</University>
</Universities>
<Countries>
<Country>Nigeria</Country>
</Countries>
<EMAILS>
<Email>7jimade@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ayoola</Name>
<MidName>A</MidName>
<Family>Awosika</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>College of Medicine, University of Illinois</Organization>
</Organizations>
<Universities>
<University>College of Medicine, University of Illinois</University>
</Universities>
<Countries>
<Country>USA</Country>
</Countries>
<EMAILS>
<Email>ayoolaawosika@yahoo.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Chika</Name>
<MidName>CI</MidName>
<Family>Idaguko</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Departments of Anatomy and Physiology, Edo State University Uzairue</Organization>
</Organizations>
<Universities>
<University>Departments of Anatomy and Physiology, Edo State University Uzairue</University>
</Universities>
<Countries>
<Country>Nigeria</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ehitare</Name>
<MidName>E</MidName>
<Family>Ekhoye</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Departments of Anatomy and Physiology, Edo State University Uzairue</Organization>
</Organizations>
<Universities>
<University>Departments of Anatomy and Physiology, Edo State University Uzairue</University>
</Universities>
<Countries>
<Country>Nigeria</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Artificial night lighting</KeyText></KEYWORD><KEYWORD><KeyText>Circadian rhythm</KeyText></KEYWORD><KEYWORD><KeyText>Community health</KeyText></KEYWORD><KEYWORD><KeyText>Hormones</KeyText></KEYWORD><KEYWORD><KeyText>Menarche</KeyText></KEYWORD><KEYWORD><KeyText>Reproductive health</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140233.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Adverse health effects of nighttime lighting: comments on American medical association policy statement. Am J Prev Med. 2013;45(3):343-6.##Martin ME, Doros P. Health risks of light at night the good, the bad, and the time of day of bioactive blue light. A Circadian White Paper. 2016;2180(781):439-633.##Sun ZS, Albrecht U, Zhuchenko O, Bailey J, Eichele G, Lee CC. RIGUI, a putative mammalian ortholog of the Dro-sophila period gene. Cell. 1997;90(6):1003-11.##Yan L, Okamura H. Gradients in the circadian expression of Per1 and Per2 genes in the rat suprachiasmatic nucleus. Eur J Neurosci. 2002;15(7):1153-62.##Sharafati-Chaleshtori R, Shirzad H, Rafieian-Kopaei M, Soltani A. Melatonin and human mitochondrial diseases. J Res Med Sci. 2017;22:2.##Figueiro MG, Rea MS. Preliminary evidence that light through the eyelids can suppress melatonin and phase shift dim light melatonin onset. BMC Res Notes. 2012;5:221. ##Falchi F, Cinzano P, Duriscoe D, Kyba CC, Elvidge CD, Baugh K, et al. The new world atlas of artificial night sky brightness. Sci Adv. 2016;2(6):e1600377.##Weinert D, Waterhouse J. Interpreting circadian rhythms. In Biological timekeeping: clocks, rhythms and behaviour. New Delhi, India: Springer; 2017. p. 23-45.##Cao M, Xu T, Yin D. Understanding light pollution: recent advances on its health threats and regulations. J Environ Sci (China). 2023;127:589-602. ##Lu J, Zou R, Yang Y, Bai X, Wei W, Ding R, et al. Association between nocturnal light exposure and melatonin in humans: a meta-analysis. Environ Sci Pollut Res Int. 2024;31(3):3425-34.##Mahoney MM. Shift work, Jet lag, and female reproduction. Int J Endocrinol. 2010;2010:813764.##Haim A, Portnov BA. Light pollution as a new risk factor for human breast and prostate cancers. Dordrecht: Springer; 2013 Jun 3.##Adeniyi MJ, Agoreyo FO, Olorunnisola OL, Olaniyan OT, Seriki SA, Ozolua PO, et al. Photo-pollution disrupts reproduc-tive homeostasis in female rats: The duration-dependent role of selenium administrations. Chin J Physiol. 2020;63(5):235-43.##Adeniyi MJ, and Agoreyo FO. Duration-related modulation of body temperature rhythm and reproductive cycle in rats by photoperiodic perturbation. DRJHP. 2020;8(1):1-6.##Hu C, Jia W. Linking MTNR1B variants to diabetes: the role of circadian rhythms. Diabetes. 2016;65(6):1490-2.##Garenne M. Age at menarche in Nigerian demographic surveys. J Biosoc Sci. 2021;53(5):745-57.##Barrett KE, Barman SM, Boitano S, Brooks HL. Ganong’s review of medical physiology. McGraw-Hill Companies, Inc.; 2010##Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. Gonadotropin-releasing hormone receptors. En-docr Rev. 2004;25(2):235-75.##Okeke CO, Ekakitie OO, Adeniyi MJ, Oyeyemi AW, Ajayi OI. Interrelationship between surging reproductive hormones and blood viscosity indices in apparently healthy females. J Krishna Inst Med Sci Univ. 2023;12(2):57-64.##Ige SF, Adeniyi MJ, Ayanlere OJ, Doeh AO. Allium cepa juice prevented oxidative stress-mediated metabolic disorder following chronic lead acetate exposure in male rats. Albanian J Med Health Sci. 2019;140):11.##Marieb EN, Hoehn K. Human anatomy &amp; physiology. Pearson education; 2007.##Veldhuis JD, Keenan DM, Liu PY, Iranmanesh A, Takahashi PY, Nehra AX. The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback. Mol Cell Endocrinol. 2009;299(1): 14-22.##Lowden A, Moreno C, Holmback U, Lennernas M, Tucker P. Eating and shift work–effects on habits, metabolism and performance. Scand J Work Environ Health. 2010;36(2):150-62.##Verheijen FJ. Photopollution: artificial light optic spatial control systems fail to cope with. Incidents, causation, remedies. Exp Biol. 1985;44(1):1-18.##Hong SL, Jack N, Jeong TK, Gon K. The reality of light pollution: a field survey for the determination of lighting envi-ronmental management zones in South Korea sustainability. 2018;10(2):374.##Touitou Y, Reinberg A, Touitou D. Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: health impacts and mechanisms of circadian disruption. Life Sci. 2017;193:94-106.##Adeniyi MJ, Agoreyo FO. Diurnal effect of selenium supplementations on adult female wistar rats made hypothyroid by methimazole. Biomed J Sci Tech Res. 2017;1(2):283-5.##Wang Y, Fang G, Mingfen D, Lan G, Ciyong L, Canquan Z, et al. Rotating shift work and menstrual characteristics in a cohort of Chinese Nurses. BMC Womens Health. 2016;16:24.##Yorshinaka K, Yamaguchi A, Matsumura R, Node K, Tokuda I, Akashi M. Effect of different light-dark schedules on estrous cycle in mice and implications for mitigating the adverse impact of night work. Genes Cells. 2017;22(10):876-84.##Aliyu AA, Amadu L. Urbanization, cities, and health: the challenges to Nigeria–a review. Ann Afr Med. 2017;16(4):149-58.##Wizor CH, Anthony-Leo EN. Spatial analysis of urban street lights infrastructure in port harcourt metropolis, rivers state, Nigeria. Int J Sci Res. 2020;9(2):198-206.##Ogoro M, Smiles JE, Dollah OC. Spatial trend of light pollution in obio/akpor lga, rivers state, Nigeria. Int J Novel Res Civil Struct Earth Sci. 2020;7(2):1-7.##Gilbert KM, Shi Y. Nighttime lights and urban expansion: illuminating the correlation between built-up areas of lagos city and changes in climate parameters. Buildings. 2023;13(12):2999.##Ahemen I, Amah AN, Agada PO. A survey of power supply and lighting patterns in north central nigeria—the energy saving potentials through efficient lighting systems. Energ Buildings. 2016; 133:770-6.##The genesis of Power Generation in Nigeria. Nigerian Econom. 1987;1:40.##Simpson ES. Electricity production in nigeria. Econom Geography. 1969;45(3):239-57.##Tunau KA, Adamu AN, Hassan MA, Ahmed Y, Ekele BA. Age at menarche among school girls in Sokoto, Northern Nigeria. Ann Afr Med. 2012;11(2):103-7. ##Monyei CG, Adewumi AO, Obolo MO, Sajou B. Nigeria&#39;s energy poverty: Insights and implications for smart policies and framework towards a smart Nigeria electricity network. Renew Sustain Energy Rev. 2018;81:1582-601.##Adeniyi MJ, Agoreyo FO. nigeria and the selenium micronutrient: a review. Ann Med Health Sci Res. 2018;8:5-11.##Gaston KJ, Bennie J, Davies TW, Hopkins J. The ecological impacts of nighttime light pollution: a mechanistic apprais-al. Biol Rev Camb Philos Soc. 2013;88(4):912-27.##Li XM, Li S, Huang FY, Wang Z, Zhang ZY, Chen SC, et al. Artificial light at night triggers negative impacts on nutrients cycling and plant health regulated by soil microbiome in urban ecosystems. Geoderma. 2023;436:116547.##Nwankwo M, Barnabas D, Wilson OH. Relationship between age at menarche and anthropometric profiles, demogra-phy, and ethnicity among adolescent girls in Nigeria. Ann Bioanthropol. 2016;4:(1):1.##Adienbo OM, Erigbali VT. Age at menarche, menstrual characteristics and associated factors among adolescent girls in indigenous population in Niger delta region, Nigeria. J Adv Med Med Res. 2021;33(10):24-32.##Ovuakporaye SI, Eze KN, Blessing N, Shalom UN, Avwerosuoghene O. Variations in the age of onset of menarche among inhabitants of rural and urban areas in delta state south-south Nigeria. World J Biol Pharm Health Sci. 2023;14(1):168-75.##Ikaraoha CI, Mbadiwe IC, Igwe CU, Allagua D, Mezie O. Menarchial age of secondary school girls in urban and rural areas of rivers state, Nigeria. 2005;2:4.##Oyewole OA, Oduwole A, Adediran AS. Age of pubertal maturation of girls in South Western Nigeria. Niger J Med. 2022;31:443-6.##Raji Y, Osonuga OA, Shittu OI, Akinsomisoye OS, Togun VA, Azeez MO. Age at menarche and its predicting factors in cities of ibadan and ogbomoso of southwestern Nigeria. J Med Sci. 2006;6(5): 772-8.##Diorgu FC, Diorgu KN. Average pubertal timing, characteristics and menstrual patterns of Nigerian girls: Implication for sex education. J Gynecol Res Obstet. 2020;6(1):10-3.##Anikwe CC, Mamah JE, Okorochukwu BC, Nnadozie UU, Obarezi CH, Ekwedigwe KC. Age at menarche, menstrual characteristics, and its associated morbidities among secondary school students in Abakaliki, southeast Nigeria. Heli-yon. 2020;6(5):e04018.##Rehan N. Characteristics of the menarche in Hausa girls in Nigeria. J Obstet Gynaecol (Lahore). 1994;14(4):265-8.##Sulayman HU, Ameh N, Adesiyun AG, Ozed-Williams IC, Ojabo AO, Avidime S, et al. Age at menarche and preva-lence of menstrual abnormalities among adolescents in Zaria, northern Nigeria. Ann Nigerian Med. 2013;7(2):66-70.##Attia AM, Montaser BA, Abdallah NK. Role of melatonin in constitutional delayed puberty in boys. Menoufia Med J. 2020;33:283-7.##Cohen HN, Hay HC, Annesley T, Beastall G, Wallace A, Spooner R, et al. Rapid communication: serum immunoreac-tive melatonin in boys with delayed puberty. Clin Endocrinol (Oxf). 1982;17(5):517-21.##Agoreyo FO, Adeniyi MJ. Pattern of estrous cycle and ovarian antiperoxidative activity in light deprived sprague-dawley rats treated with sodium selenite. J Med Res Biol Stud. 2018;1(1):103.##Adeniyi MJ, Agoreyo FO, Ige SF, Fabunmi OA, Ozolua OP, Biliaminu SA. Physiological implications of prolonged sele-nium administrations in normal and desynchronized adult female rats. J Krishna Institute of Med Sciences. 2021:10(4):21-36.##Ansel L, Bolborea M, Bentsen AH, Klosen P, Mikkelsen JD, Simonneaux V. Differential regulation of kiss1 expression by melatonin and gonadal hormones in male and female Syrian hamsters. J Biol Rhythms. 2010;25(2):81-91. ##Pazarci P, Kaplan H, Alptekin D, Yilmaz M, L&#252;leyap U, Singirik E, et al. The effects of daylight exposure on melatonin levels, Kiss1 expression, and melanoma formation in mice. Croat Med J. 2020;61(1):55-61.##Pielecka-Fortuna J, Zhiguo C, Suzanne MM. Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol. Endocrinology. 2008;149(4):1979-86. ##Rhie YJ. Kisspeptin/G protein-coupled receptor-54 system as an essential gatekeeper of pubertal development. Ann Pediatr Endocrinol Metab. 2013;18(2):55-9.##Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet. 2006;15 Spec No 2:R271-7.##Costa G. Shift work and health: current problems and preventive actions. Saf Health Work. 2010;1(2):112-23. ##Isah EC, Iyamu OA, Imoudu GO. Health effects of night shift duty on nurses in a university teaching hospital in Benin city, Nigeria. Niger J Clin Pract. 2008;11(2):144-8. ##Idowu O, Fajemilehin BR, Awvioro T, Abass V, Adetoye C. Assessment and predictors of shift work disorder among nurses in selected Nigerian teaching hospital. Int J Nurs Midwife Health Related Cases. 2018;4(6):1-9.##Bakare KO, Omiwale CB. Work shift and women’s health in hotels in Ile-Ife, Osun State, Nigeria. MOJ Womens Health. 2017;5(1):178-82.##Miyauchi F, Nanjo K, Otsuka K. [Effect of continuous lighting on secretion of melatonin and pituitary hormones in women]. Nihon Sanka Fujinka Gakkai Zasshi. 1991;43(5):529-34.##Davis S, Dana KM, Chu C, Frank ZS. Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev. 2012;21(4):609-18.  ##Lee Barron M. Light exposure, melatonin secretion, and menstrual cycle parameters: an integrative review. Biol Res Nurs. 2007;9(1):49-69.##Prata Lima MF, Baracat EC, Sim&#245;es MD. Effect of melatonin and the ovarian response to pinealectomy and to con-tinuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res. 2004;37(7):987-95.##Vladimir NA. Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett. 2006:27(1-2):35-52.##Chernova IV. Light regimens and estrous cycle in rats. Med Acad J. 2005;3(7):45-6.##Adeniyi MJ, Agoreyo FO. Estrous cycle ratio as a reproductive index in the rats. Am J Biomed Sci Res. 2019;4(2):100-3. ##Ige SF, Adeniyi MJ, Iyalla GO. Allium cepa mitigates aluminum chloride-induced hepatotoxicity in male wistar rats. J Biomed Sci. 2017;6(4):27.##Araujo-Lopes R, Crampton JR, Aquino NS, Miranda RM, Kokay IC, Reis AM, et al. Prolactin regulates kisspeptin neu-rons in the arcuate nucleus to suppress LH secretion in female rats. Endocrinology. 2014;155(3):1010-20.##Luo E, Stephens SB, Chaing S, Munaganuru N, Kauffman AS, Breen KM. Corticosterone blocks ovarian cyclicity and the LH surge. Endocrinology. 2016;157(3):1187-99. ##Fadeyi A, Ayoka AO, Fawale MB, Alabi QB, Oluwadaisi AM, Omole JG. Prevalence, predictors and effects of shift work sleep disorder among nurses in a Nigerian teaching hospital. Sleep Sci Practice. 2018;6:1-9.##Adeniyi MJ, Awosika A, Millis MR, Ige SF. Occupational stress-related sleep anomaly in frontline COVID-19 health workers: the possible underlying mechanisms. identifying occupational stress and coping strategies. 2023 Feb 28. IntechOpen.##Adeniyi M. Impacts of environmental stressors on autonomic nervous system. autonomic nervous system. In auto-nomic nervous system-special interest topics 2022 Jan 23. IntechOpen.##Awosika A, Adeniyi MJ. Occupation-related stress and stress-related risk factors among nurses in west Africa. Middle East Res J Med Sci. 2023;3(1):9-16.##Awosika A, Adeniyi MJ, Okojie AK, Okeke C. Photic stress and rhythmic physiological processes: roles of selenium as a chronobiotic. InSelenium and Human Health. 2023 Mar 4. IntechOpen.##Childs GV, Odle AK, MacNicol MC, MacNicol AM. The importance of leptin to reproduction. Endocrinology. 2021;162(2):bqaa204. ##Chung S. Growth and puberty in obese children and implications of body composition. J Obes Metab Syndr. 2017;26(4):243-50.##Nazem TG, Ackerman KE. The female athlete triad. Sports Health. 2012;4(4):302-11.##Adeniyi MJ, Fabunmi O, Okojie AK, Olorunnisola OL, Odetola AA, Olaniyan OT, et al. Impact of night study frequen-cy on sleep pattern, anthropometrical indices and peripheral oxygen saturation in age-matched nigerian female stu-dents prior to semester examination. Int J Biomed Sci. 2020;16(3):37-42.##Abay KA, Amare M. Night light intensity and women’s body weight: evidence from Nigeria. Econ Hum Biol. 2018;31:238-48.##Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PloS Med. 2004;1(3):e62.##Jeremiah AM, Soladoye AO. Plasma lipid profile and uric acid in high fat fed female rats treated with oral contracep-tive. Biomed J Sci Tech Res. 2017;1(2):526-35.##Aladashvili-Chikvaidze N, Kristesashvili J, Gegechkori M. Types of reproductive disorders in underweight and over-weight young females and correlations of respective hormonal changes with BMI. Iran J Reprod Med. 2015;13(3):135-40.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Association of NOX5 Expression with Sperm Activity and Motility in Pathospermic Infertile Men</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140235</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: The newest NOX isoform, NOX5, has been found in mammalian spermatozoa. Many physiological and pathological situations in spermatozoa are mediated by reactive oxygen species (ROS). NOX5 is the main source of ROS in spermatozoa. Our purpose was to investigate the changes in NOX5 expression and the effect of NOX5 expression on sperm motility, chromatin integrity, and oxidative status in oligoasthenozoospermic compared to normozoospermic men.&lt;br /&gt;
Methods: Semen samples were collected from 30 normozoospermic (NS) and 30 oligoasthenozoospermic (OAS) men. NOX5 protein expression in sperm samples was evaluated by immunohistochemistry and western blot. Oxidative stress status was evaluated by total antioxidant capacity (TAC), total oxidant capacity (TOC), and oxidative stress index (OSI) parameters. Chromatin integrity in spermatozoa was evaluated by toluidine blue staining.&lt;br /&gt;
Results: NOX5 expression levels were significantly higher in OAS group than in NS group (p&lt;0.001). In addition, chromatin integrity was significantly higher in the OAS group in comparison to NS group (p&lt;0.001). TAC levels were higher in the NS group, but OSI and TOC levels were significantly higher in OAS group (p&lt;0.001). It was found that NOX5 protein expression was positively correlated with oxidative stress and chromatin integrity and negatively correlated with motility (p&lt;0.01).&lt;br /&gt;
Conclusion: These results suggest that overexpression of NOX5 may be the source of excessive ROS production and oxidative stress injuries in oligoasthenozoospermic men. Considering that NOX5 expression is positively correlated with oxidative stress and chromatin integrity but negatively correlated with motility, it can be considered a biomarker to be used in assisted reproductive procedures.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>184</FPAGE>
            <TPAGE>193</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Benay</Name>
<MidName>B</MidName>
<Family>Daylan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Histology and Embryology, Istanbul Medipol University, School of Medicine</Organization>
</Organizations>
<Universities>
<University>Department of Histology and Embryology, Istanbul Medipol University, School of Medicine</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email>benaydaylan94@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Oya</Name>
<MidName>O</MidName>
<Family>Korkmaz</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Histology and Embryology, Malatya Turgut Ozal University, School of Medicine</Organization>
</Organizations>
<Universities>
<University>Department of Histology and Embryology, Malatya Turgut Ozal University, School of Medicine</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Olgu</Name>
<MidName>OE</MidName>
<Family>Tok </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Histology and Embryology, Istanbul Medipol University, School of Medicine</Organization>
</Organizations>
<Universities>
<University>Department of Histology and Embryology, Istanbul Medipol University, School of Medicine</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Cagri</Name>
<MidName>C</MidName>
<Family>Cakici</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University</Organization>
</Organizations>
<Universities>
<University>Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Turkan</Name>
<MidName>T</MidName>
<Family>Yigitbasi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University</Organization>
</Organizations>
<Universities>
<University>Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ayse</Name>
<MidName>A</MidName>
<Family>Karahasanoglu</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Medipol Mega University Hospital, IVF Center</Organization>
</Organizations>
<Universities>
<University>Medipol Mega University Hospital, IVF Center</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Tuba</Name>
<MidName>TV</MidName>
<Family>Yelke</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Medipol Mega University Hospital, IVF Center</Organization>
</Organizations>
<Universities>
<University>Medipol Mega University Hospital, IVF Center</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Tugba</Name>
<MidName>TS</MidName>
<Family>Ustabas</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Medipol Mega University Hospital, IVF Center</Organization>
</Organizations>
<Universities>
<University>Medipol Mega University Hospital, IVF Center</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sule</Name>
<MidName>S</MidName>
<Family>Ayla</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Histology and Embryology, Istanbul Medeniyet University, School of Medicine</Organization>
</Organizations>
<Universities>
<University>Department of Histology and Embryology, Istanbul Medeniyet University, School of Medicine</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Male infertility</KeyText></KEYWORD><KEYWORD><KeyText>NADPH oxidase 5</KeyText></KEYWORD><KEYWORD><KeyText>Reactive oxygen  species</KeyText></KEYWORD><KEYWORD><KeyText>Sperm motility</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140235.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care. Hum Reprod. 2017;32(9):1786-801.##Hotaling JM. Genetics of male infertility. Urol Clin North Am. 2014;41(1):1-17.##Virtanen HE, Toppari J. Cryptorchidism and fertility. Endocrinol Metab Clin North Am. 2015;44(4):751-60.##Parvin A, Erabi G, Alemi A, Rezanezhad A, Maleksabet A, Sadeghpour S, et al. Seminal plasma proteomics as putative biomarkers for male infertility diagnosis. Clin Chim Acta. 2024;561:119757.##Andrabi SW, Ara A, Saharan A, Jaffar M, Gugnani N, Esteves SC. Sperm DNA fragmentation: causes, evaluation and management in male infertility. JBRA Assist Reprod. 2024;28(2):306-19.##de Lamirande E, Gagnon C. Reactive oxygen species and human spermatozoa. I. effects on the motility of intact spermatozoa and on sperm axonemes. J Androl. 1992;13(5):368-78.##Aitken RJ. Possible redox regulation of sperm motility activation. J Androl. 2000;21(4):491-6.##Griveau JF, Le Lannou D. Effects of antioxidants on human sperm preparation techniques. Int J Androl. 1994;17(5):225-31.##de Lamirande E, Gagnon C. Impact of reactive oxygen species on spermatozoa: a balancing act between beneficial and detrimental effects. Hum Reprod. 1995;10 Suppl 1:15-21.##O&#39;Flaherty C. Redox regulation of mammalian sperm capacitation. Asian J Androl. 2015;17(4):583-90.##Aitken RJ. The role of free oxygen radicals and sperm function. Int J Androl. 1989;12(2):95-7.##Iwasaki A, Gagnon C. Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil Steril. 1992;57(2):409-16.##B&#225;nfi B, Moln&#225;r G, Maturana A, Steger K, Heged&#251;s B, Demaurex N, et al. A Ca(2 )-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem. 2001;276(40):37594-601.##Setyawan EMN, Kim MJ, Oh HJ, Kim GA, Jo YK, Lee SH, et al. Spermine reduces reactive oxygen species levels and decreases cryocapacitation in canine sperm cryopreservation. Biochem Biophys Res Commun. 2016;479(4):927-32.##Sabeur K, Ball BA. Characterization of NADPH oxidase 5 in equine testis and spermatozoa. Reproduction. 2007;134(2):263-70.##Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 2001; 269(1-2):131-40.##BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B, et al. NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med. 2007;42(4):446-59.##Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, Bommarius B, et al. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol. 2003;285(2):C353-69.##Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, et al. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol. 2008;52(22):1803-9.##Peng JJ, Liu B, Xu JY, Peng J, Luo XJ. NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension. Naunyn Schmiedebergs Arch Pharmacol. 2017;390(4):331-8.##Tarafdar A, Pula G. The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int J Mol Sci. 2018;19(12):3824.##Wright C, Milne S, Leeson H. Sperm DNA damage caused by oxidative stress: modifiable clinical, lifestyle and nutritional factors in male infertility. Reprod Biomed Online. 2014;28(6):684-703.##Vatannejad A, Tavilani H, Sadeghi MR, Amanpour S, Shapourizadeh S, Doosti M. Evaluation of ROS-TAC Score and DNA damage in fertile normozoospermic and infertile asthenozoospermic males. Urol J. 2017;14(1):2973-8.##World health organization. WHO laboratory manual for the examination and processing of human semen. 6th ed. Geneva: World health organization; 2021. 276 p.##Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112-9.##Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11.##Kim HS, Kang MJ, Kim SA, Oh SK, Kim H, Ku SY, et al. The utility of sperm DNA damage assay using toluidine blue and aniline blue staining in routine semen analysis. Clin Exp Reprod Med. 2013;40(1):23-8.##Ghani E, Keshtgar S, Habibagahi M, Ghannadi A, Kazeroni M. Expression of NOX5 in human teratozoospermia compared to normozoospermia. Andrologia. 2013;45(5):351-6.##Musset B, Clark RA, DeCoursey TE, Petheo GL, Geiszt M, Chen Y, et al. NOX5 in human spermatozoa: expression, function, and regulation. J Biol Chem. 2012;287(12):9376-88.##Vatannejad A, Tavilani H, Sadeghi MR, Karimi M, Lakpour N, Amanpour S, et al. Evaluation of the NOX5 protein expression and oxidative stress in sperm from asthenozoospermic men compared to normozoospermic men. J Endocrinol Invest. 2019;42(10):1181-9.##Keshtgar S, Ghani E. Impact of calcium and reactive oxygen species on human sperm function: Role of NOX5. Andrologia. 2022;54(8):e14470.##Aitken RJ, Clarkson JS. Significance of reactive oxygen species and antioxidants in defining the efficacy of sperm preparation techniques. J Androl. 1988;9(6):367-76.##Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod. 1989;41(1):183-97.##De Iuliis GN, Wingate JK, Koppers AJ, McLaughlin EA, Aitken RJ. Definitive evidence for the nonmitochondrial production of superoxideanion by human spermatozoa. J Clin Endocrinol Metab. 2006;91(5):1968-75.##Aitken RJ, Ryan AL, Baker MA, McLaughlin EA. Redox activity associated with the maturation and capacitation of mammalian spermatozoa. Free Radic Biol Med. 2004;36(8):994-1010.##Hong J, Behar J, Wands J, Resnick M, Wang LJ, Delellis RA, et al. Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S. Cancer Res. 2010;70(3):1247-55.##Pourmasumi S, Khoradmehr A, Rahiminia T, Sabeti P, Talebi AR, Ghasemzadeh J. Evaluation of sperm chromatin integrity using aniline blue and toluidine blue staining in infertile and normozoospermic men. J Reprod Infertil. 2019;20(2):95-101.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>The Impact of NADPH Oxidase 5 Activity and Reactive Oxygen Species on Ca-pacitated Human Sperm</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140238</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Progesterone (P4) activates sperm calcium channels (CatSper), allowing calcium to enter the cell, which activates NADPH Oxidase-5 (NOX5) and produces reactive oxygen species (ROS). While calcium and ROS are essential for sperm capacitation, the role of NOX5 in capacitated sperm is unclear. This study investigated NOX5 activity in capacitated human sperm.&lt;br /&gt;
Methods: Forty semen samples from fertile men were processed, with motile sperm separated and divided into nine groups: control (Ham&#39;s F-10), solvent (DMSO), progesterone, diphenyleneiodonium chloride (DPI, NOX5 inhibitor), phorbol-12-myristate 13-acetate (PMA, NOX5 activator), P4+DPI, P4+PMA, Trolox, and P4+Trolox. Sperm kinematics, membrane integrity, survival rate, and ROS production was evaluated. Data were analyzed using ANOVA and Kruskal-Wallis tests, p&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;font-family:Symbol&quot;&gt;&#163;&lt;/span&gt;&lt;/span&gt;0.05 considered statistically significant.&lt;br /&gt;
Results: Progressive motility significantly decreased with DPI (56.2&#177;2.1%) and PMA (56.5&#177;2.1%), both alone and combined with progesterone (58.0&#177;2.0% and 57.4&#177;2.2%), compared to the progesterone group (66.0&#177;1.9%). No significant change was observed in the Trolox groups. Progesterone, alone or combined with DPI, PMA, and Trolox, significantly reduced sperm linearity from 0.6&#177;0.01 to 0.5&#177;0.01%. Straightline velocity decreased in P4+PMA and P4+Trolox groups (88.2&#177;4.4 and 89.7&#177;3.9 &lt;em&gt;μm/s&lt;/em&gt;) compared to the control group (105.0&#177;5.5 &lt;em&gt;μm/s&lt;/em&gt;). Trolox reduced ROS content, while other treatments had no effect on ROS levels.&lt;br /&gt;
Conclusion: NOX5 does not play a prominent role in capacitated sperm. The negative effects of PMA and DPI on sperm motility appear independent of their actions on NOX5 and ROS production. Trolox did not affect sperm motility and survival, indicating that capacitated sperm require little or no ROS.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>193</FPAGE>
            <TPAGE>201</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mohammad</Name>
<MidName>M</MidName>
<Family>Hojjati Far</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sara</Name>
<MidName>S</MidName>
<Family>Keshtgar</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>keshtgar@sums.ac.ir, keshtgars@yahoo.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Narges</Name>
<MidName>N</MidName>
<Family>Karbalaei</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>NADPH oxidase 5</KeyText></KEYWORD><KEYWORD><KeyText>Reactive oxygen  species</KeyText></KEYWORD><KEYWORD><KeyText>Progesterone</KeyText></KEYWORD><KEYWORD><KeyText>Spermatozoa</KeyText></KEYWORD><KEYWORD><KeyText>Sperm capacitation</KeyText></KEYWORD><KEYWORD><KeyText>Trolox</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140238.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Lee KH, Hwang JY. Ca2  homeostasis and male fertility: a target for a new male contraceptive system. Anim Cells Syst (Seoul). 2024;28(1):171-83.##Gagnon C, de Lamirande E. Controls of sperm motility. The sperm cell: production, maturation, fertilization, regeneration. Cambridge: Uk; 2006:108-33.##Puga Molina LC, Luque GM, Balestrini PA, Marin-Briggiler CI, Romarowski A, Buffone MG. Molecular basis of human sperm capacitation. Front Cell Dev Biol. 2018;6:72.##Delgado-Bermudez A, Yeste M, Bonet S, Pinart E. A review on the role of bicarbonate and proton transporters during sperm capacitation in mammals. Int J Mol Sci. 2022;23(11):6333.##Dai P, Zou M, Cai Z, Zeng X, Zhang X, Liang M. pH homeodynamics and male fertility: a coordinated regulation of acid-based balance during sperm journey to fertilization. Biomolecules. 2024;14(6):685.##Marín-Briggiler CI, Jha KN, Chertihin O, Buffone MG, Herr JC, Vazquez-Levin MnH, et al. Evidence of the presence of calcium/calmodulin-dependent protein kinase IV in human sperm and its involvement in motility regulation. J Cell Sci. 2005;118(Pt 9):2013-22.##O&#39;Flaherty C. Redox regulation of mammalian sperm capacitation. Asian J Androl. 2015;17(4):583-90.##Naz RK, Rajesh PB. Role of tyrosine phosphorylation in sperm capacitation/acrosome reaction. Reprod Biol Endocrinol. 2004;2:75.##Luconi M, Francavilla F, Porazzi I, Macerola B, Forti G, Baldi E. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids. 2004;69(8-9):553-9.##Jiang F, Zhu Y, Chen Y, Tang X, Liu L, Chen G, et al. Progesterone activates the cyclic AMP-protein kinase a signalling pathway by upregul-ating ABHD2 in fertile men. J Int Med Res. 2021;49(3):300060521999527.##Musset B, Clark RA, DeCoursey TE, Petheo GL, Geiszt M, Chen Y, et al. NOX5 in human spermatozoa: expression, function, and regulation. J Biol Chem. 2012;287(12):9376-88.##Aitken RJ, Baker MA. The role of genetics and oxidative stress in the etiology of male infertility-a unifying hypothesis? Front Endocrinol (Lausanne). 2020;11:581838.##Chianese R, Pierantoni R. Mitochondrial reactive oxygen species (ROS) production alters sperm quality. Antioxidants (Basel). 2021;10(1):92.##Petrushanko IY, Lobachev VM, Kononikhin AS, Makarov AA, Devred F, Kovacic H, et al. Oxidation of Са2 -Binding Domain of NADPH Oxidase 5 (NOX5): Toward Understanding the Mechanism of Inactivation of NOX5 by ROS. PloS One. 2016;11(7):e0158726.##Touyz RM, Anagnostopoulou A, Rios F, Montezano AC, Camargo LL. NOX5: molecular biology and pathophysiology. Exp Physiol. 2019;104(5):605-16.##Keshtgar S, Ghani E. Impact of calcium and reactive oxygen species on human sperm function: role of NOX5. Andrologia. 2022;54(8):e14470.##Tirone F, Cox JA. NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin. FEBS Lett. 2007;581(6):1202-8.##Chen F, Yu Y, Haigh S, Johnson J, Lucas R, Stepp DW, et al. Regulation of NADPH oxidase 5 by protein kinase C isoforms. PloS One. 2014;9(2):e88405.##Kirichok Y, Lishko PV. Rediscovering sperm ion channels with the patch-clamp technique. Mol Hum Reprod. 2011;17(8):478-99.##Strunker T, Goodwin N, Brenker C, Kashikar ND, Weyand I, Seifert R, et al. The CatSper channel mediates progesterone-induced Ca2  influx in human sperm. Nature. 2011;471(7338):382-6.##Lishko PV, Botchkina I, Kirichok Y. Progesterone activates the principal Ca2  channel of human sperm. Nature. 2011;471(7338):387-91.##Ghanbari H, Keshtgar S, Zare HR, Gharesi-Fard B. Inhibition of CatSper and Hv1 channels and NOX5 enzyme affect progesterone-induced increase of intracellular calcium concentration and ROS generation in human sperm. Iran J Med Sci. 2019;44(2):127-34.##Ghanbari H, Keshtgar S, Kazeroni M. Inhibition of the CatSper channel and NOX5 enzyme activity affects the functions of the progesterone-stimulated human sperm. Iran J Med Sci. 2018;43(1):18-25.##World Health O. WHO laboratory manual for the examination and processing of human semen. 6th ed. Geneva: World Health Organization; 2021. 290 p.##Jokiniemi A, Magris M, Ritari J, Kuusipalo L, Lundgren T, Partanen J, et al. Post-copulatory genetic matchmaking: HLA-dependent effects of cervical mucus on human sperm function. Proc Biol Sci. 2020;287(1933):20201682.##Keshtgar S, Ghanbari H, Ghani E, Shid Moosavi SM. Effect of CatSper and Hv1 channel inhibition on progesterone stimulated human sperm. J Reprod Infertil. 2018;19(3):133-9.##Goodson SG, White S, Stevans AM, Bhat S, Kao CY, Jaworski S, et al. CASAnova: a multiclass support vector machine model for the classification of human sperm motility patterns. Biol Reprod. 2017;97(5):698-708.##Miller MR, Mannowetz N, Iavarone AT, Safavi R, Gracheva EO, Smith JF, et al. Unconventional endocannabinoid signaling governs sperm activ-ation via the sex hormone progesterone. Science. 2016;352(6285):555-9.##Calogero AE, Burrello N, Barone N, Palermo I, Grasso U, D&#39;Agata R. Effects of progesterone on sperm function: mechanisms of action. Hum Reprod. 2000;15 Suppl 1:28-45.##Armstrong JS, Bivalacqua TJ, Chamulitrat W, Sikka S, Hellstrom WJ. A comparison of the NADPH oxidase in human sperm and white blood cells. Int J Androl. 2002;25(4):223-9.##Teijeiro JM, Marini PE, Bragado MJ, Garcia-Marin LJ. Protein kinase C activity in boar sperm. Andrology. 2017;5(2):381-91.##Aitken RJ, Harkiss D, Knox W, Paterson M, Irvine DS. A novel signal transduction cascade in capacitating human spermatozoa characterised by a redox-regulated, cAMP-mediated induction of tyrosine phosphorylation. J Cell Sci. 1998;111(Pt 5):645-56.##Pullar JM, Hampton MB. Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. J Biol Chem. 2002;277(22):19402-7.##Zavadskis S, Weidinger A, Hanetseder D, Banerjee A, Schneider C, Wolbank S, et al. Effect of diphenyleneiodonium chloride on intracellular reactive oxygen species metabolism with emphasis on NADPH oxidase and mitochondria in two therapeutically relevant human cell types. Pharmaceutics. 2020;13(1):10.##Ghani E, Keshtgar S, Habibagahi M, Ghannadi A, Kazeroni M. Expression of NOX5 in human teratozoospermia compared to normozoospermia. Andrologia. 2013;45(5):351-6.##Keshtgar S, Ebrahimi B, Shid-Moosavi SM, Erfani N. NADPH oxidase 5 activation; a novel approach to human sperm cryoinjury. Cell Tissue Bank. 2020;21(4):675-84.##Homa ST, Vessey W, Perez-Miranda A, Riyait T, Agarwal A. Reactive oxygen species (ROS) in human semen: determination of a reference range. J Assist Reprod Genet. 2015;32(5):757-64.##Ribas-Maynou J, Yeste M. Oxidative stress in male infertility: causes, effects in assisted reproductive techniques, and protective support of antioxidants. Biology (Basel). 2020;9(4):77.##Dutta S, Majzoub A, Agarwal A. Oxidative stress and sperm function: a systematic review on evaluation and management. Arab J Urol. 2019;17(2):87-97.##Villaverde AI, Netherton J, Baker MA. From past to present: the link between reactive oxygen species in sperm and male infertility. Antioxidants (Basel). 2019;8(12):616.##Cos P, Hermans N, Calomme M, Maes L, De Bruyne T, Pieters L, et al. Comparative study of eight well-known polyphenolic antioxidants. J Pharm Pharmacol. 2003;55(9):1291-7.##Keshtgar S, Iravanpour F, Gharesi-Fard B, Kazero-oni M. Combined effect of trolox and EDTA on frozen-thawed sperm quality. Iran J Med Sci. 2016;41(3):230-7.##Garrido N, Meseguer M, Simon C, Pellicer A, Re-mohi J. Pro-oxidative and anti-oxidative imbalance in human semen and its relation with male fertility. Asian J Androl. 2004;6(1):59-65.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>The Protective Effects of Citrulline on Testicular Injury Induced by Torsion and Detorsion in Adult Male Rats: An Experimental Study</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140241</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Testicular torsion is a critical urological emergency that can lead to testicular ischemia and significant tissue damage. Citrulline, a supplement known for enhancing cellular metabolism and mitigating oxidative stress and inflammation, has been explored for its protective effects against testicular injury resulting from torsion and detorsion in rat models.&lt;br /&gt;
Methods: This study involved 42 Wistar rats, divided into six groups: Sham, torsion/detorsion (T/D), and four groups receiving varying doses of Citrulline (300, 600, 900 &lt;em&gt;mg/kg&lt;/em&gt;) and vitamin E (20 &lt;em&gt;mg/kg&lt;/em&gt;). A surgical procedure was performed to induce torsion by rotating the left testicle for 4 &lt;em&gt;hr&lt;/em&gt;, followed by reperfusion. Daily oral administration of the supplements continued for one week post-surgery. Assessments included oxidative stress markers, apoptosis, inflammation, pathology, and sperm parameters. Statistical analysis was conducted using GraphPad Prism.&lt;br /&gt;
Results: Citrulline administration at doses of 600 and 900 &lt;em&gt;mg/kg&lt;/em&gt; significantly reduced malondialdehyde (MDA) and reactive oxygen species (ROS) levels. Additionally, it increased glutathione (GSH) levels and decreased protein carbonyl levels at the 900 &lt;em&gt;mg/kg&lt;/em&gt; dose. The expression of interleukin-6 (IL-6) decreased at 900 &lt;em&gt;mg/kg&lt;/em&gt;, tumor necrosis factor-alpha (TNF-α) levels dropped at 600 and 900 &lt;em&gt;mg/kg&lt;/em&gt;, and the pro-apoptotic factor Bax was reduced at all doses. Sperm analysis showed improved sperm count and motility at the 900&lt;em&gt; mg/kg&lt;/em&gt; dose. Histological examination revealed significant positive effects of Citrulline on testicular tissue.&lt;br /&gt;
Conclusion: Citrulline effectively lowers oxidative stress, inflammation, while enhancing sperm quality and pathological outcomes. These results indicate that Citrulline has potential as a therapeutic agent for testicular torsion.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>201</FPAGE>
            <TPAGE>211</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Vida</Name>
<MidName>V</MidName>
<Family>Motamed Nia </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Nastaran</Name>
<MidName>N</MidName>
<Family>Rezaei</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad</Name>
<MidName>M</MidName>
<Family>Shokati Sayyad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad</Name>
<MidName>M</MidName>
<Family>Seyedabadi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fereshteh</Name>
<MidName>F</MidName>
<Family>Talebpour Amiri</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName>F</MidName>
<Family>Shaki</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>fshaki.tox@gmail.com</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Citrulline</KeyText></KEYWORD><KEYWORD><KeyText>Inflammation</KeyText></KEYWORD><KEYWORD><KeyText>Torsion</KeyText></KEYWORD><KEYWORD><KeyText>Oxidative stress</KeyText></KEYWORD><KEYWORD><KeyText>Testis</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140241.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Magalh&#227;es JA, Ribeiro LS, Rego JPA, de Andrade CR. Current markers for infertility in men. JBRA Assist Reprod. 2021;25(4):592-600.##Dokmeci D. Testicular torsion, oxidative stress and the role of antioxidant therapy. Folia Med (Plovdiv). 2006;48(3-4):16-21.##Tavasli B, K&#246;seoğlu H, &#199;evik H. Segmental ischemia in testicular torsion. Proc (Bayl Univ Med Cent). 2016;29(1):59-9.##Shimizu S, Tsounapi P, Dimitriadis F, Higashi Y, Shimizu T, Saito M. Testicular torsion–detorsion and potential therapeutic treatments: a possible role for ischemic postconditioning. Int J Urol. 2016;23(6):454-63.##Jacobsen FM, Rudlang TM, Fode M, &#216;stergren PB, S&#248;nksen J, Ohl DA, et al. The impact of testicular torsion on testicular function. World J Mens Health. 2020;38(3):298-307.##Fouad AA, Qutub HO, Jresat I. Dose‐dependent protective effect of baicalin against testicular torsion–detorsion in rats. Andrologia. 2017;49(1).##Wei SM, Yan ZZ, Zhou J. Involvement of reactive oxygen species and TATA box-binding protein-related factor 2 in testicular torsion/detorsion-induced injury. Urology. 2013;81(2):466.e9-14.##Meštrović J, Drmić-Hofman I, Pogorelić Z, Vilović K, Šupe-Domić D, Šešelja-Perišin A, et al. Beneficial effect of nifedipine on testicular torsion-detorsion injury in rats. Urology. 2014;84(5):1194-8.##Mohamed DI, Abou-Bakr DA, Ezzat SF, El-Kareem HFA, Nahas HHA, Saad HA, et al. Vitamin D3 prevents the deleterious effects of testicular torsion on testis by targeting miRNA-145 and ADAM17: in silico and in vivo study. Pharmaceuticals (Basel). 2021;14(12):1222.##Ozdemirkan A, Kurtipek AC, Kucuk A, Ozdemir C, Yesil S, Sezen SC, et al. Effect of cerium oxide on kidney and lung tissue in rats with testicular torsion/detorsion. Biomed Res Int. 2022;2022:3176455.##Lavallee ME, Cash J. Testicular torsion: evaluation and management. Curr Sports Med Rep. 2005;4(2):102-4.##Ringdahl E, Teague L. Testicular torsion. Am Fam Physician. 2006;74(10):1739-43.##Burud IAS, Alsagof SMI, Ganesin R, Selvam ST, Zakaria NAB, Tata MD. Correlation of ultrasonography and surgical outcome in patients with testicular torsion. Pan Afr Med J. 2020;36:45.##Karaguzel E, Kadihasanoglu M, Kutlu O. Mechanisms of testicular torsion and potential protective agents. Nat Rev Urol. 2014;11(7):391-9.##Ahmed MA, Ahmed AA, El Morsy EM. Acetyl-11-keto-β-boswellic acid prevents testicular torsion/detorsion injury in rats by modulating 5-LOX/LTB4 and p38-MAPK/JNK/Bax/Caspase-3 pathways. Life Sci. 2020;260:118472.##Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, B&#233;nazeth S, et al. Almost all about citrulline in mammals. Amino Acids. 2005;29(3):177-205.##Hassel C, Couchet M, Jacquemot N, Blavignac C, Lo&#239; C, Moinard C, et al. Citrulline protects human retinal pigment epithelium from hydrogen peroxide and iron/ascorbate induced damages. J Cell Mol Med. 2022;26(10):2808-18.##Jegatheesan P, Beutheu S, Freese K, Waligora-Dupriet AJ, Nubret E, Butel MJ, et al. Preventive effects of citrulline on western diet-induced non-alcoholic fatty liver disease in rats. Br J Nutr. 2016;116(2):191-203.##Abbasi S, Azin S, Fani M, Soltani M, Abtahi-Eivary H, Moghimian M. The effect of Origanum vulgare on histological damage, oxidative stress and sperm parameters following induction of ischemia/reperfusion in adult testicular rat. Sci J Kurdistan Univ Med Sci. 2022;27(2):1-14.##Kuriyama K, Kitamura T, Yokoi R, Hayashi M, Kobayashi K, Kuroda J, et al. Evaluation of testicular toxicity and sperm morphology in rats treated with methyl methanesulphonate (MMS). J Reprod Dev. 2005;51(5):657-67.##Yokoi K, Uthus EO, Nielsen FH. Nickel deficiency diminishes sperm quantity and movement in rats. Biol Trace Element Res. 2003;93(1-3):141-54.##Habibi E, Arab-Nozari M, Elahi P, Ghasemi M, Shaki F. Modulatory effects of Viola odorata flower and leaf extracts upon oxidative stress-related damage in an experimental model of ethanol-induced hepatotoxicity. Appl Physiol Nutr Metab. 2019;44(5):521-7.##Souza &#193;dPBd, Oliveira MMRd, Andrade RRd, Amorim RFBd, Bocca AL, Borin MdF. The in vivo effect of L-arginine on skin elasticity in mice. Brazilian J Pharm Sci. 2017;53(3):e00045.##Karimi Sh, Hosseinimehr SJ, Mohammadi HR, Khalatbary AR, Amiri FT. Zataria multiflora ameliorates cisplatin-induced testicular damage via suppression of oxidative stress and apoptosis in a mice model. Iran J Basic Med Sci. 2018;21(6):607-14.##Rousar T, Kucera O, Lotkova H, Cervinkova Z. Assessment of reduced glutathione: comparison of an optimized fluorometric assay with enzymatic recycling method. Anal Biochem. 2012;423(2):236-40.##Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res. 2007;631(1):55-61.##Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329(1-2):23-38.##Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909-50.##Moazamian R, Polhemus A, Connaughton H, Fraser B, Whiting S, Gharagozloo P, et al. Oxidative stress and human spermatozoa: diagnostic and functional significance of aldehydes generated as a result of lipid peroxidation. Mol Hum Reprod. 2015;21(6):502-15.##Tremellen K. Oxidative stress and male infertilit--a clinical perspective. Hum Reprod Update. 2008;14(3):243-58.##Chow CK. Interrelationships of cellular antioxidant defense systems. InCellular antioxidant defense mechanisms. US: CRC Press; 2019. p. 217-38.##Cai B, Luo Yl, Wang SJ, Wei WY, Zhang XH, Huang W, et al. Does citrulline have protective effects on liver injury in septic rats? Biomed Res Int. 2016;2016:1469590.##Liu Y, Fu X, Gou L, Li S, Lan N, Zheng Y, et al. L-citrulline protects against glycerol-induced acute renal failure in rats. Renal Fail. 2013;35(3):367-73.##Zhou JQ, Xu X, Zhen WW, Luo YL, Cai B, Zhang S. Protective effect of citrulline on the hearts of rats with sepsis induced by cecal ligation and puncture. Biomed Res Int. 2018;2018:2574501.##Elshaari F, Elfagih R, Sheriff D, Barassi I. Testicular torsion-detorsion-histological and biochemical changes in rat testis. J Cytol Histol. 2012;3(01):1000316.##Ahmed MA, Ahmed AA, El Morsy EM. Acetyl-11-keto-β-boswellic acid prevents testicular torsion/detorsion injury in rats by modulating 5-LOX/LTB4 and p38-MAPK/JNK/Bax/Caspase-3 pathways. Life Sci. 2020;260:118472.##Kasper M, Roehlecke C, Witt M, Fehrenbach H, Hofer A, Miyata T, et al. Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. Am J Respir Cell Mol Biol. 2000;23(4):485-91.##Xue Y, Zhang Y, Chen L, Wang Y, Lv Z, Yang LQ, et al. Citrulline protects against LPS‑induced acute lung injury by inhibiting ROS/NLRP3‑dependent pyroptosis and apoptosis via the Nrf2 signaling pathway. Exp Ther Med. 2022;24(4):632.##Saad AE, Zoghroban HS, Ghanem HB, El-Guindy DM, Younis SS. The effects of L-citrulline adjunctive treatment of Toxoplasma gondii RH strain infection in a mouse model. Acta Trop. 2023;239:106830.##Doğan G, İpek H. The protective effect of Ganoderma lucidum on testicular torsion/detorsion-induced ischemia-reperfusion (I/R) injury. Acta Cir Bras. 2020;35(1):e202000103.##Niki E. Lipid oxidation that is, and is not, inhibited by vitamin E: Consideration about physiological functions of vitamin E. Free Radical Biol Med. 2021;176:1-1.##Zhang X, Zhang J, Cai Z, Wang X, Lu W, Li H. Effect of unilateral testicular torsion at different ages on male fertility. J Int Med Res. 2020;48(4):0300060520918792.##Gielchinsky I, Suraqui E, Hidas G, Zuaiter M, Landau EH, Simon A, et al. Pregnancy rates after testicular torsion. J Urol. 2016;196(3):852-5.##Sun J, Liu GH, Zhao HT, Shi CR. Long-term influence of prepubertal testicular torsion on spermatogenesis. Urol Int. 2006;77(3):275-8.##Abdelzaher WY, Mostafa-Hedeab G, Sayed AboBakr Ali AH, Fawzy MA, Ahmed AF, Bahaa El-deen MA, et al. Idebenone regulates sirt1/Nrf2/TNF-α pathway with inhibition of oxidative stress, inflammation, and apoptosis in testicular torsion/detorsion in juvenile rats. Hum Exp Toxicol. 2022;41:09603271221102515.##Yapanoglu T, Ozkaya F, Yilmaz AH, Mammadov R, Cimen FK, Hirik E, et al. Effect of etoricoxib on experimental oxidative testicular ischemia-reperfusion damage in rats induced with torsion-detorsion. Korean J Physiol Pharmacol. 2017;21(5):457-64.##Liu H, Shi M, Li X, Lu W, Zhang M, Zhang T, et al. Adipose mesenchymal stromal cell-derived exosomes prevent testicular torsion injury via activating PI3K/AKT and MAPK/ERK1/2 pathways. Oxid Med Cell Longev. 2022;2022:8065771.##Flores-Ram&#237;rez AG, Tovar-Villegas VI, Maharaj A, Garay-Sevilla ME, Figueroa A. Effects of L-citrulline supplementation and aerobic training on vascular function in individuals with obesity across the lifespan. Nutrients. 2021;13(9):2991.##Xu X, Wu C, Jia G, Zhao H, Chen X, Wang J. Citrulline: Modulation on protein synthesis, intestinal homeostasis and antioxidant status. Int J Nutr Sci. 2019;4(2):1033.##Ho SW, El-Nezami H, Corke H, Ho CS, Shah NP. L-citrulline enriched fermented milk with Lactobacillus helveticus attenuates dextran sulfate sodium (DSS) induced colitis in mice. J Nutr Biochem. 2022;99:108858.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Cesarean Section and Its Impact on Uterine Artery Resistance and the Risk of Pre-eclampsia in Subsequent Pregnancies</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140240</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: The purpose of the current study was to compare the color Dop-pler findings of uterine arteries and perinatal outcomes in pregnant women with and without previous cesarean section (C/S).&lt;br /&gt;
Methods: This cohort study enrolled 308 pregnant women aged 20-35 without underlying diseases, with at least one previous pregnancy and childbirth. The participants were divided into two groups: 154 women without C/S and 154 women with C/S. Baseline data were collected, followed by uterine artery Dop-pler scans. Then, the perinatal outcomes, including pre-eclampsia, intrauterine growth restriction (IUGR), premature delivery, and birth weight were evaluated.&lt;br /&gt;
Results: The average age of patients in the C/S group was 30.46&#177;3.81, which was significantly higher than the non-C/S group (28.86&#177;4.64). It was found that uterine artery resistance was higher in women with C/S history (1.11&#177;0.44, p&lt;0.001) compared to those without (1.00&#177;0.37, p&lt;0.001). Pre-eclampsia inci-dence was also higher in C/S group (16.1%, p=0.042) compared to non-C/S group (9.1%, p=0.042). The incidence of preterm birth in the C/S group (p=0.209), the incidence of IUGR (p=0.791), and the average birth weight (p=0.291) in the two groups did not differ significantly.&#160; The average gestational age in the C/S group was 37.54&#177;1.4, and in the non-C/S group was 38.01&#177;1.99 weeks. The results were not affected by potential confounders such as age, the time interval between pregnancies, and also body mass index.&lt;br /&gt;
Conclusion: Previous cesarean section can significantly increase the uterine ar-tery resistance in subsequent pregnancy.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>211</FPAGE>
            <TPAGE>219</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Neda</Name>
<MidName>N</MidName>
<Family>Hashemi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Arash</Name>
<MidName>A</MidName>
<Family>Mohazzab</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>School of Public Health, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>School of Public Health, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Maryam</Name>
<MidName>M</MidName>
<Family>Moshfeghi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for  Reproductive Biomedicine, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for  Reproductive Biomedicine, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Samaneh</Name>
<MidName>S</MidName>
<Family>Rokhgireh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Roya</Name>
<MidName>R</MidName>
<Family>Derakhshan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Nasrin</Name>
<MidName>N</MidName>
<Family>Sanaei Nasab</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS)</Organization>
</Organizations>
<Universities>
<University>Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS)</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>nasrin_sanaei@yahoo.com</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Cesarean section</KeyText></KEYWORD><KEYWORD><KeyText>Color doppler ultrasonography</KeyText></KEYWORD><KEYWORD><KeyText>Pre-eclampsia</KeyText></KEYWORD><KEYWORD><KeyText>Uterine artery resistance</KeyText></KEYWORD><KEYWORD><KeyText>Uterine artery</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140240.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks&#39; gestation. Obstet Gynecol. 2000;96(4):559-64.##Zhang J, Merialdi M, Platt LD, Kramer MS. Defining normal and abnormal fetal growth: promises and challenges. Am J Obstet Gynecol. 2010;202(6):522-8.##Ciobanu A, Formuso C, Syngelaki A, Akolekar R, Nicolaides KH. Prediction of small-for-gestational-age neonates at 35-37 weeks&#39; gestation: contribution of maternal factors and growth velocity between 20 and 36 weeks. Ultrasound Obstet Gynecol. 2019;53(4):488-95.##van Zijl MD, Koullali B, Mol BWJ, Snijders RJ, Kazemier BM, Pajkrt E. The predictive capacity of uterine artery Doppler for preterm birth-A cohort study. Acta Obstet Gynecol Scand. 2020;99(4):494-502.##Roberts LA, Ling HZ, Poon LC, Nicolaides KH, Kametas NA. Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction. Ultrasound Obstet Gynecol. 2018;52(4):507-14.##Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2004;18(3):383-96.##Llurba E, Turan O, Kasdaglis T, Harman CR, Baschat AA. Emergence of late-onset placental dysfunction: relationship to the change in uterine artery blood flow resistance between the first and third trimesters. Am Perinatol. 2013;30(6):505-12.##Boerma T, Ronsmans C, Melesse DY, Barros AJD, Barros FC, Juan L, et al. Global epidemiology of use of and disparities in caesarean sections. Lancet. 2018;392(10155):1341-8.##Betran AP, Torloni MR, Zhang JJ, G&#252;lmezoglu AM. WHO statement on caesarean section rates. BJOG. 2016;123(5):667-70.##Gurol-Urganci I, Bou-Antoun S, Lim CP, Cromwell DA, Mahmood TA, Templeton A, et al. Impact of caesarean section on subsequent fertility: a systematic review and meta-analysis. Hum Reprod. 2013;28(7):1943-52.##Ye J, Betr&#225;n AP, Guerrero Vela M, Souza JP, Zhang J. Searching for the optimal rate of medically necessary cesarean delivery. Birth. 2014;41(3):237-44.##Torabi S, Sheikh M, Fattahi Masrour F, Shamshirsaz AA, Bateni ZH, Nassr AA, et al. Uterine artery doppler ultrasound in second pregnancy with previous elective cesarean section. Matern Fetal Neonatal Med. 2019;32(13):2221-7.##Yapan P, Tachawatcharapunya S, Surasereewong S, Thongkloung P, Pooliam J, Poon LC, et al. Uterine artery doppler indices throughout gestation in women with and without previous cesarean deliveries: a prospective longitudinal case-control study. Sci Rep. 2022;12(1):20913.##Aygun EG, Karabuk E, Dilek TUK. A retrospective cohort study to determine whether the previous route of delivery affects the uterine artery blood flow. Cureus. 2023;15(5):e39552.##Barati M, Shahbazian N, Ahmadi L, Masihi S. Diagnostic evaluation of uterine artery Doppler sonography for the prediction of adverse pregnancy outcomes. J Res Med Sci. 2014;19(6):515-9.##Işıkalan MM, Yeni&#231;eri H, Toprak E, G&#252;leroğlu FY, Acar A. Effect of previous cesarean sections on second-trimester uterine artery Doppler. J Obstet Gynaecol Res. 2020;46(9):1766-71.##Jamshed S, Chien SC, Tanweer A, Asdary RN, Hardhantyo M, Greenfield D, et al. Correlation between previous caesarean section and adverse maternal outcomes accordingly with robson classification: systematic review and meta-analysis. Front Med (Lausanne). 2022;8:740000.##Wang L, Wang J, Lu N, Liu J, Diao F. Pregnancy and perinatal outcomes of patients with prior cesarean section after a single embryo transfer in IVF/ICSI: a retrospective cohort study. Front Endocrinol (Lausanne). 2022;13:851213.##Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, et al. First-trimester uterine artery doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women. Ultrasound Obstet Gynecol. 2014;43(5):500-7.##Toal M, Keating S, Machin G, Dodd J, Adamson SL, Windrim RC, et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol. 2008;198(3):330.e1-7.##Li H, Gudmundsson S, Olofsson P. Clinical significance of uterine artery blood flow velocity waveforms during provoked uterine contractions in high-risk pregnancy. Ultrasound Obstet Gynecol. 2004;24(4):429-34.##St Clair NE, Batra M, Kuzminski J, Lee AC, O&#39;Callahan C. Global challenges, efforts, and controversies in neonatal care. Clin Perinatol. 2014;41(4):749-72.##Abdel-Razik M, El-Berry S, Mostafa A. The effects of nitric oxide donors on uterine artery and sub-endometrial blood flow in patients with unexplained recurrent abortion. J Reprod Infertil. 2014;15(3):142-6.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Cervical Anatomical Characteristics in Women with Endometriosis: A Diagnostic Approach</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140234</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Endometriosis is a gynecologic disorder which causes dysmenorrhea and infertility. Early diagnosis of endometriosis can help prevent the necessity for invasive diagnostic procedures. Medical imaging has been widely utilized to diagnose various diseases without the need for invasive procedures. The purpose of this study was to investigate the cervical length in women with endometriosis.&lt;br /&gt;
Methods: In this case-control study, the case group consisted of nulliparous women with endometriosis, while the control group comprised nulliparous women without endometriosis. A total of 42 individuals were included in each group. Cervical length was measured using transvaginal ultrasound from the external os to the internal os. The patients in the case group underwent laparoscopy to confirm the diagnosis. Pearson chi-square test and Fisher’s exact test were employed to compare categorical variables with a p&lt;0.05 considered statistically significant.&lt;br /&gt;
Results: In both groups, there were no notable variations in any of the demographic characteristics. However, the severity of dysmenorrhea was significantly different between the two groups (p=0.01). The average diameter of the mediolateral cervix (29.48&#177;6.2 and 27.14&#177;3.8) was statistically significant between the patient group and control group, respectively (p=0.04). The mediolateral width may have a positive predictive effect on the presence of endometriosis, while cervical length appears to have a protective effect against endometriosis.&lt;br /&gt;
Conclusion: Demographic data do not predict endometriosis. This study suggests that mediolateral width in transvaginal sonography can serve as a minimally invasive diagnostic tool for endometriosis, showing correlation with endometriosis symptoms like dysmenorrhea and dyspareunia.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>219</FPAGE>
            <TPAGE>224</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Elahe</Name>
<MidName>E</MidName>
<Family>Afshari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Roya</Name>
<MidName>R</MidName>
<Family>Derakhshan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Shahla</Name>
<MidName>Sh</MidName>
<Family>Chaichian</Family>
<NameE>Shahla</NameE>
<MidNameE></MidNameE>
<FamilyE>Chaichian</FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>shchaichian@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Seyed Reza</Name>
<MidName>SR</MidName>
<Family>Saadat Mostafavi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiology, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Radiology, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Shima</Name>
<MidName>Sh</MidName>
<Family>Ghafourian Noroozi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiology, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Radiology, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Samaneh</Name>
<MidName>S</MidName>
<Family>Rokhgireh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Abolfazl</Name>
<MidName>A</MidName>
<Family>Mehdizadehkashi</Family>
<NameE>Abolfazl</NameE>
<MidNameE></MidNameE>
<FamilyE>Mehdizadehkashi</FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Babak</Name>
<MidName>B</MidName>
<Family>Sabet</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Artificial Intelligence, Smart University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Artificial Intelligence, Smart University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohanna</Name>
<MidName>M</MidName>
<Family>Khandan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Student Research Committee, Mazandaran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Student Research Committee, Mazandaran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Cervical length measurement</KeyText></KEYWORD><KEYWORD><KeyText>Endometrial thickness</KeyText></KEYWORD><KEYWORD><KeyText>Endometriosis</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140234.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1-354.e12.##Vitale SG, Capriglione S, Peterlunger I, La Rosa VL, Vitagliano A, Noventa M, et al. The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxidative Med Cell Longev. 2018;2018:7924021.##Davoodi P, J Ghadimi D, Rezaei M, Khazei Tabari MA, Shirani A, Nouri B, et al. Endometriosis and COVID-19: Clinical presentation and quality of life, a systematic review. J Obstet Gynecol Cancer Res. 2023;8(4):315-26.##Della Corte L, Di Filippo C, Gabrielli O, Reppuccia S, La Rosa VL, Ragusa R, et al. The burden of endometriosis on women’s lifespan: a narrative overview on quality of life and psychosocial wellbeing. Int J Environ Res Public Health. 2020;17(13):4683.##Benacerraf BR, Groszmann Y. Sonography should be the first imaging examination done to evaluate patients with suspected endometriosis. J Ultrasound Med. 2012;31(4):651-3.##Tripoli TM, Sato H, Sartori MG, de Araujo FF, Gir&#227;o MJ, Schor E. Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis. J Sex Med. 2011;8(2):497-503.##Sherif MF, Badawy ME, Elkholi DG. Accuracy of magnetic resonance imaging in diagnosis of deeply infiltrating endometriosis. Egyptian J Radiol Nuclear Med. 2015;46(1):159-65.##Bagaria SJ, Rasalkar DD, Paunipagar BK. Imaging tools for endometriosis: role of ultrasound, MRI and other imaging modalities in diagnosis and planning intervention. Endometriosis Basic Concepts Curr Res Trends. 2012;24:437-47.##Exacoustos C, Zupi E, Piccione E. Ultrasound imaging for ovarian and deep infiltrating endo-metriosis. Semin Reprod Med. 2017;35(1):5-24.##Marcellin L, Santulli P, Pinzauti S, Bourdon M, Lamau MC, Borghese B, et al. Age at menarche does not correlate with the endometriosis phenotype. PLoS One. 2019;14(7):e0219497.##Nnoaham KE, Webster P, Kumbang J, Kennedy SH, Zondervan KT. Is early age at menarche a risk factor for endometriosis? a systematic review and meta-analysis of case-control studies. Fertil Steril. 2012;98(3):702-12.e6.##Waller KG, Shaw RW. Risk factors for endo-metriosis: menstrual and life-style characteristics. Med Principles Pract. 1998;7(2):127-33.##Tang Y, Zhao M, Lin L, Gao Y, Chen GQ, Chen S, et al. Is body mass index associated with the incidence of endometriosis and the severity of dysmenorrhoea: a case–control study in China? BMJ Open. 2020;10(9):e037095.##Sel&#231;uk A, Bayraktar M, G&#252;rb&#252;z A, Alkan A, Sadiye E. Uterine junctional zone thickness, cervical length and bioelectrical impedance analysis of body composition in women with endometriosis. Balkan Med J. 2012;29(4):410-3.##Tajeran Gh, Derakhshan R, Jayervand F, Rahimi M, Hajari P, Hashemi N. The predictive value of transvaginal cervical length and cervical angle ultrasonography in term delivery outcomes: a cohort study. J Matern Fetal Neonatal Med. 2024;37(1):2406344.##Tosti C, Zupi E, Exacoustos C. Could the uterine junctional zone be used to identify early-stage endometriosis in women? Womens Health (Lond). 2014;10(3):225-7.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Assisted Reproductive Technology Outcomes After Ethanol Sclerotherapy in Poor Responder Patients with Endometriomas: A Before-After Clinical Trial</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140239</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: The purpose of the present study was to investigate the assisted reproductive technology (ART) outcomes after ethanol sclerotherapy (EST) in poor responder patients with endometriomas.&lt;br /&gt;
Methods: In this before-after clinical trial, the outcomes of ART of 31 poor responders with endometriomas were evaluated after EST between July 2023 to March 2024. These patients had undergone ART at least in one cycle before and did not respond well. Recurrence rate, antral follicle count (AFC), anti-M&#252;llerian hormone (AMH), and relief of symptoms including dysmenorrhea and abnormal uterine bleeding (AUB) were evaluated before the procedure. Follow-up assessments were conducted two and six weeks after the procedure for evaluating the complications. Fisher’s exact test, chi-square test, and paired sample t-test were used for statistical analysis using SPSS 24.&lt;br /&gt;
Results: In this study, the levels of AFC and AMH increased significantly after endometrioma stripping therapy (p&lt;0.05). Additionally, the number of embryos obtained increased significantly, indicating potential improvement in oocyte quality. There was a significant reduction in pelvic pain scores (p=0.001), as well as a notable decrease in dysmenorrhea (p=0.02) and dyspareunia (p=0.001). Moreover, 16.12% of patients reported recovery from intermenstrual bleeding. However, no significant difference was observed in the amount of gonadotropin used (p=0.56).&lt;br /&gt;
Conclusion: EST is an appropriate and safe procedure before ART for poor responders who have endometriomas and can be a replacement for surgery among selected patients.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>224</FPAGE>
            <TPAGE>231</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Farah</Name>
<MidName>F</MidName>
<Family>Ghasemi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Arash Women&amp;#39;s Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Arash Women&#39;s Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>mahsamoshiri00@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ladan</Name>
<MidName>L</MidName>
<Family>Kashani</Family>
<NameE>لادن</NameE>
<MidNameE></MidNameE>
<FamilyE>کاشانی</FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Arash Women&amp;#39;s Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Arash Women&#39;s Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ashraf</Name>
<MidName>A</MidName>
<Family>Moini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Endocrinology and Female Infertility Unit, Arash Women&amp;#39;s Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Endocrinology and Female Infertility Unit, Arash Women&#39;s Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Maryam</Name>
<MidName>M</MidName>
<Family>Farid Mojtahedi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Arash Women&amp;#39;s Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Arash Women&#39;s Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Roza</Name>
<MidName>R</MidName>
<Family>Shahhosseini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Arash Women&amp;#39;s Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Arash Women&#39;s Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Farzaneh</Name>
<MidName>F</MidName>
<Family>Alemohammad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Arash Women&amp;#39;s Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Arash Women&#39;s Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>ART outcome</KeyText></KEYWORD><KEYWORD><KeyText>Ethanol sclerotherapy</KeyText></KEYWORD><KEYWORD><KeyText>Endometrioma</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140239.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Jee BC. Efficacy of ablation and sclerotherapy for the management of ovarian Endomerioma:A narrative review. Clin Exp Reprod Med. 2022;49(2):76-86.##Tsolakidis D, Pados G, Vavilis D, Athanatos D, Tsalikis T, Giannakou A, et al. The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. Fertil Steril. 2010;94(1):71-7.##Pais AS, Flagothier C, Tebache L, Almeida Santos T, Nisolle M. Impact of surgical management of endometrioma on AMH levels and pregnancy rates: a review of recent literature. J Clin Med. 2021;10(3):414.##Benaglia L, Somigliana E, Vighi V, Ragni G, Vercellini P, Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod. 2010;25(3):678-82.##Gao X, Zhang Y, Xu X, Lu S, Yan L. Effects of ovarian endometrioma aspiration on in vitro fertilization-intracytoplasmic sperm injection and embryo transfer outcomes: a systematic review and meta-analysis. Arch Gynecol Obstet. 2022;306(1):17-28.##Tomassetti C, Adamson D, Arici A, et al. EndoART: a prospective randomized controlled trial on endometriomas in assisted reproductive technologies, comparing the effect of no intervention, surgery, and prolonged GnRH downregulation on pregnancy rates. J Endometr Pelvic Pain Disord. 2018;10(3):158-73.##Soliman M, Sisson B. What is sclerotherapy? What to expect and all else you need to know. Updated December 12, 2021. Available from: [https://www.sciencedirect.com/science/article/pii/S0972978X21001288].##Martinez-Garcia JM, Candas B, Suarez-Salvador E, Gomez M, Merino E, Castellarnau M, et al. Comparing the effects of alcohol sclerotherapy with those of surgery on anti-mullerian hormone and ovarian reserve after endometrioma treatment: a prospective multicenter pilot cohort study. Eur J Obstet Gynecol Reprod Biol. 2021;259:60-6.##Chen Y, Pei H, Chang Y, Chen M, Wang H, Xie H, et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-M&#252;llerian hormone: a prospective cohort study. J Ovarian Res. 2014;7:108.##Han MT, Cheng W, Zhu R, Wu HH, Ding J, Zhao NN, et al. The cytokine profiles in follicular fluid and reproductive outcomes in women with endometriosis. Am J Reprod Immunol. 2023;89(6):e13633.##Mu&#241;oz-Hernando L, Mu&#241;oz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-Garc&#237;a &#193;, Lopez-Gonzalez G, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015;7:595-603.##Kalaitzopoulos DR, Samartzis N, Daniilidis A, Leeners B, Makieva S, Nirgianakis K, et al. Effects of vitamin D supplementation in endometriosis: a systematic review. Reprod Biol Endocrinol. 2022;20(1):176.##Leibetseder A, Schoeffmann K, Keckstein J, Keckstein S. Endometriosis detection and localization in laparoscopic gynecology. Multimed Tools Appl. 2022;81(5):6191-215.##Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB. Management of ovarian endometriomas. Hum Reprod Update. 2002;8(6):591-7.##Park HJ, Kim H, Lee GH, Yoon TK, Lee WS. Could surgical management improve the IVF outcomes in infertile women with endometrioma? Obstet Gynecol Sci. 2019;62(1):1-10.##Garc&#237;a-Tejedor A, Castellarnau M, Ponce J, Eulalia F, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimally invasive procedure. Eur J Obstet Gynecol Reprod Biol. 2015;18:25-29.##Kim GH, Kim PH, Shin JH, Nam IC, Chu HH, Ko HK. Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis. Eur Radiol. 2022;32(3):1726-37.##Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12.##S&#225;nchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20:17-30.##Zhu W, Tan Z, Fu Z, Li X, Chen X, Zhou Y. Repeat transvaginal ultrasound-guided aspiration of ovarian endometrioma in infertile women with endometriosis. Am J Obstet Gynecol. 2011;204:61.e1-6.##Alborzi S, Ravanbakhsh R, Parsanezhad ME, Alborzi M, Alborzi S, Dehbashi S. A comparison of follicular response of ovaries to ovulation induction after laparoscopic ovarian cystectomy or fenestration and coagulation versus normal ovaries in patients with endometrioma. Fertil Steril. 2007;88(2):507-9.##Chan LY, So WW, Lao TT. Rapid recurrence of endometrioma after transvaginal ultrasound-guided aspiration. Eur J Obstet Gynecol Reprod Biol. 2003;109(2):196-8.##Donnez J, Nisolle M, Gillerot S, Anaf V, Clerckx-Braun F, Casanas-Roux F. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62(1):63-6.##Gon&#231;alves FC, Andres MP, Passman LJ, Gon&#231;alves MO, Podgaec S. A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma. Int J Gynaecol Obstet. 2016;134(1):3-7.##Huang L, Chang MY, Shiau CS, Hsieh TT. Changes in anti-M&#252;llerian hormone after ultrasound-guided aspiration and ethanol sclerotherapy of ovarian cyst. Taiwan J Obstet Gynecol. 2021;60(3):509-51.##Garcia-Tejedor A, Martinez-Garcia JM, Candas B, Suarez E, Manalich L, Gomez M, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. 2020;27(5):1133-40.##Suganuma N, Wakahara Y, Ishida D, Asano M, Kitagawa T, Katsumata Y, et al. Pretreatment for ovarian endometrial cyst before in vitro fertilization. Gynecol Obstet Invest. 2002;54 Suppl 1:36-40; discussion 41-2.##Hsieh CL, Shiau CS, Lo LM, Hsieh TT, Chang MY. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril. 2009;91(6):2709-13.##Alborzi S, Zahiri Sorouri Z, Askari E, Poordast T, Chamanara K. The success of various endometrioma treatments in infertility: a systematic review and meta-analysis of prospective studies. Reprod Med Biol. 2019;18(4):312-22.##Cohen A, Almong B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117-24.e5.##Alborzi S, Askary E, Keramati P, Alamdarloo SM, Poordast T, Ashraf MA, et al. Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: prospective cross-sectional study. Reprod Med Biol. 2021;20(3):313-20.##Alborzi S, Namavar Jahromi B, Ahmadbeigi M. Recovery rate of patients with recurrent ovarian endometriomas using sclerotherapy with 95% ethanol. J Obstet Gynaecol Cancer Res. 2018;3(3):105-10.##Ikuta A, Tanaka Y, Mizokami T, Tsutsumi A, Sato M, Tanaka M, et al. Management of transvaginal ultrasound-guided absolute ethanol sclerotherapy for ovarian endometriotic cysts. J Med Ultrason (2001). 2006;33(2):99-103.##Yazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, et al. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009;19(1):121-5.##Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001;72(1):35-9.##Chang MY, Hsieh CL, Shiau CS, Hsieh TT, Chiang RD, Chan CH. Ultrasound-guided aspiration and ethanol sclerotherapy (EST) for treatment of cyst recurrence in patients after previous endometriosis surgery: analysis of influencing factors using a decision tree. J Minim Invasive Gynecol. 2013;20(5):595-603.##Miquel L, Preaubert L, Gnisci A, Resseguier N, Pivano A, Perrin J, et al. Endometrial ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis: retrospective cohort study. PLoS One. 2020;15(9):e0239846.##Tehrani HG, Tavakoli R, Hashemi M, Haghighat S. Ethanol sclerotherapy versus laparoscopic surgery in management of ovarian endometrioma; a randomized clinical trial. Arch Acad Emerg Med. 2022;10(1).##Lee JK, Ahn SH, Kim HI, Lee YJ, Kim S, Han K, et al. Therapeutic efficacy of catheter-directed ethanol sclerotherapy and its impact on ovarian reserve in patients with ovarian endometrioma at risk of decreased ovarian reserve: a preliminary study. J Minim Invasive Gynecol. 2022;29(2):317-23.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Placental Histopathological Changes and the Level of Anti-Spike Antibody After Covid-19 Vaccination During Pregnancy: A Case Series</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140236</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: COVID-19 infection during pregnancy could be associated with placental histopathological changes such as vascular diseases and malperfusion. There are studies showing that mRNA vaccines are not associated with significant placental pathological changes. Our objective was to evaluate the placental histopathology in pregnant women who received Sinopharm, an inactivated virus vaccine, during pregnancy.&lt;br /&gt;
Case Presentation: The study included placental samples collected from mothers who gave birth of living singletons through elective cesarean sections performed between March 2022 and May 2022 at Imam Khomeini Hospital Complex. The study included women who had no history of positive reverse transcription polymerase chain reaction (RT-PCR) testing for COVID-19 during pregnancy, and had received at least one dose of COVID-19 vaccine during their pregnancy. Humoral levels of anti-SARS-CoV-2 spike IgG were measured in both the mothers and neonates.&lt;br /&gt;
Results: The study included 20 mother-neonate pairs. The mean maternal age was 34&#177;3.6 years, and all mothers received Sinopharm vaccine as their first and second doses. The last vaccine dose was administered during pregnancy, with 3 mothers receiving it in the first trimester, 9 in the second trimester, and 8 in the third trimester. The histopathological findings in the placental samples included decidual vasculopathy, subchorionic thrombosis, and chronic histiocytic intervillositis. All mothers and neonates, except one pair, were positive for anti-spike antibody.&lt;br /&gt;
Conclusion: Multiple abnormal histopathological findings were reported in placenta of vaccinated mothers. However, similar to previous studies, these placental findings are considered mild lesions and have been observed in both vaccinated and unvaccinated mothers.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>231</FPAGE>
            <TPAGE>238</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Zohreh</Name>
<MidName>Z</MidName>
<Family>Heidary</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Omid</Name>
<MidName>O</MidName>
<Family>Kohandel Gargari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Student Research Committee, School of Medicine, Alborz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Student Research Committee, School of Medicine, Alborz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Majid</Name>
<MidName>M</MidName>
<Family>Zaki-Dizaji</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Human Genetics Research Center, Baqiyatallah University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Human Genetics Research Center, Baqiyatallah University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Arman</Name>
<MidName>A</MidName>
<Family>Shafiee</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Student Research Committee, School of Medicine, Alborz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Student Research Committee, School of Medicine, Alborz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Haniyeh</Name>
<MidName>H</MidName>
<Family>Fathi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Roya</Name>
<MidName>R</MidName>
<Family>Saeednejad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Irman Pathobiology Laboratory</Organization>
</Organizations>
<Universities>
<University>Irman Pathobiology Laboratory</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Marjan</Name>
<MidName>M</MidName>
<Family>Ghaemi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sedigheh</Name>
<MidName>S</MidName>
<Family>Hantoushzadeh</Family>
<NameE>صدیقه</NameE>
<MidNameE></MidNameE>
<FamilyE>حنطوش‌زاده</FamilyE>
<Organizations>
<Organization>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>hantoushzadeh@tums.ac.ir</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>COVID-19</KeyText></KEYWORD><KEYWORD><KeyText>Placenta</KeyText></KEYWORD><KEYWORD><KeyText>SARS-CoV-2</KeyText></KEYWORD><KEYWORD><KeyText>Sinopharm</KeyText></KEYWORD><KEYWORD><KeyText>Vaccine</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140236.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Kumari K, Yadav R, Mittra S, Kumar A, Singh J, Bajpai PK, et al. Pregnancy consequences and vertical transmission potential of SARS-CoV-2 infection: seeking answers from a preliminary observation. J Reprod Infertil. 2021;22(2):144-7.##Heidary Z, Kohandel Gargari O, Fathi H, Zaki-Dizaji M, Ghaemi M, Hossein Rashidi B. Maternal and neonatal complications, outcomes and possibility of vertical transmission in Iranian women with COVID-19. Arch Iran Med. 2021;24(9):713-21.##Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy. Transl Res. 2023;251:84-95.##Schwartz DA, Mulkey SB, Roberts DJ. SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical-pathologic correlations. Am J Obstet Gynecol. 2023;228(3):261-9.##Boelig RC, Aghai ZH, Chaudhury S, Kazan AS, Chan JSY, Bergmann-Leitner E. Impact of COVID-19 disease and COVID-19 vaccination on maternal or fetal inflammatory response, placental pathology, and perinatal outcomes. Am J Obstet Gynecol. 2022;227(4):652-6.##Leal CRV, Maciel RAM, Corr&#234;a J&#250;nior MD. SARS-CoV-2 infection and placental pathology. Rev Bras Ginecol Obstet. 2021;43(6):474-9.##Shanes ED, Otero S, Mithal LB, Mupanomunda CA, Miller ES, Goldstein JA. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in pregnancy: measures of immunity and placental histopathology. Obstet Gynecol. 2021;138(2):281-3.##Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273-82.##Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med. 2021;27(5):790-2.##Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, et al. COVID-19 vaccinations: the unknowns, challenges, and hopes. J Med Virol. 2022;94(4):1336-49.##Shook LL, Atyeo CG, Yonker LM, Fasano A, Gray KJ, Alter G, et al. Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infection. JAMA. 2022;327(11):1087-9.##Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, et al. Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698-713.##Arab M, Noei Teymoordash S, Talayeh M, Ghavami B, Javadi A, Nouri B. Evaluation of serologic changes of IgG and IgM antibodies associated with SARS-COV-2 in cancer patients: a cohort seroprevalence study. Asian Pac J Cancer Prev. 2021;22(6):1667-70.##Balou HA, Yaghubi Kalurazi T, Joukar F, Hassanipour S, Shenagari M, Khoshsorour M, et al. High seroprevalence of SARS-CoV-2 (COVID-19)-specific antibodies among healthcare workers: a cross-sectional study in Guilan, Iran. J Environ Public Health. 2021;2021:9081491.##Akhavan S, Borna S, Abdollahi A, Shariat M, Zamani N. Pathologic examination of the placenta and its benefits in treatment plan or follow-up of patients: a cross-sectional study. Eur J Med Res. 2022;27(1):113.##Singh N, Buckley T, Shertz W. Placental pathology in COVID-19: case series in a community hospital setting. Cureus. 2021;13(1):e12522.##Arcos J&#250;nior GF, Francisco RPV, Kill B, Peres SV, Gibelli M, Ibidi SM, et al. Placental pathological findings in coronavirus disease 2019: perinatal outcomes. Placenta. 2022;128:23-8.##Al-Rawaf SA, Mousa ET, Kareem NM. Correlation between pregnancy outcome and olacental oathology in COVID-19 oregnant women. Infect Dis Obstet Gynecol. 2022;2022:8061112.##Gulersen M, Prasannan L, Tam Tam H, Metz CN, Rochelson B, Meirowitz N, et al. Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection. Am J Obstet Gynecol MFM. 2020;2(4):100211.##Motwani R, Deshmukh V, Kumar A, Kumari C, Raza K, Krishna H. Pathological involvement of placenta in COVID-19: a systematic review. Infez Med. 2022;30(2):157-67.##Suhren JT, Meinardus A, Hussein K, Schaumann N. Meta-analysis on COVID-19-pregnancy-related placental pathologies shows no specific pattern. Placenta. 2022;117:72-7.##Prasad S, Kalafat E, Blakeway H, Townsend R, O&#39;Brien P, Morris E, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat Commun. 2022;13(1):2414.##Jeewandara C, Jayampathi KCS, Ranasinghe T, Aberathna IS, Gunasekara B, Danasekara S, et al. Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka. PLOS Glob Public Health. 2022;2(7):e0000607.##Sunder A, Alqatari HM, Taha OE, Keshta MS, Bughamar FK, Darwish B. COVID-19 vaccinations in pregnancy: save mother and baby from COVID-19 pandemic. Int J Gynaecol Obstet. 2022;160(3):864-73.##Smithgall MC, Murphy EA, Schatz-Siemers N, Matrai C, Tu J, Baergen RN, et al. Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2. Am J Obstet Gynecol. 2022;227(5):782-4.##Mohd Ariff NS, Abdul Halim Zaki I, Mohd Noordin Z, Md Hussin NS, Goh KW, Ming LC, et al. A review of the prevalence of thromboembolic complications among pregnant women infected with COVID-19. J Clin Med. 2022;11(19):5934.##Carbonnel M, Daclin C, Tourne M, Roux E, Le-Marchand M, Racowsky C, et al. Impact of COVID-19 on subclinical placental thrombosis and maternal thrombotic factors. J Clin Med. 2022;11(14):4067.##Fung TY, To KF, Sahota DS, Chan LW, Leung TY, Lau TK. Massive subchorionic thrombohematoma: a series of 10 cases. Acta Obstet Gynecol Scand. 2010;89(10):1357-61.##Miyagi M, Kinjo T, Mekaru K, Nitta H, Masamoto H, Aoki Y. Massive subchorionic thrombohematoma (Breus&#39; Mole) associated with fetal growth restriction, oligohydramnios, and intrauterine fetal death. Case Rep Obstet Gynecol. 2019;2019:9510936.##Mattuizzi A, Sauvestre F, Andr&#233; G, Poingt M, Camberlein C, Carles D, et al. Adverse perinatal outcomes of chronic intervillositis of unknown etiology: an observational retrospective study of 122 cases. Sci Rep. 2020;10(1):12611.##Schwartz DA, Baldewijns M, Benachi A, Bugatti M, Collins RRJ, De Luca D, et al. Chronic histiocytic intervillositis with trophoblast necrosis is a risk factor associated with placental infection from coronavirus disease 2019 (COVID-19) and intrauterine maternal-fetal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in live-born and stillborn infants. Arch Pathol Lab Med. 2021;145(5):517-28.##Rebutini PZ, Zanchettin AC, Stonoga ETS, Pr&#225; DMM, de Oliveira ALP, Dezid&#233;rio FDS, et al. Association between COVID-19 pregnant women symptoms severity and placental morphologic features. Front Immunol. 2021;12:685919.##Marton T, Hargitai B, Hunter K, Pugh M, Murray P. Massive perivillous fibrin deposition and chronic histiocytic intervillositis a complication of SARS-CoV-2 infection. Pediatr Dev Pathol. 2021;24(5):450-4.##Romero R, Kim YM, Pacora P, Kim CJ, Benshalom-Tirosh N, Jaiman S, et al. The frequency and type of placental histologic lesions in term pregnancies with normal outcome. J Perinat Med. 2018;46(6):613-30.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>The Migration of an Intrauterine Device in the Bladder of an Asymptomatic Woman: A Case Report</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140237</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: The use of intrauterine devices (IUDs) for contraception has in-creased in many countries. However, their application has some serious compli-cations such as uterine perforation and injury to adjacent organs. The translo-cated IUD into the bladder is a very rare occurrence.&lt;br /&gt;
Case Presentation: Our case was a 41-year-old woman whose IUD was acci-dentally discovered in her bladder during a routine ultrasound. The IUD has mi-grated from its normal position in the uterus to the bladder. The IUD was suc-cessfully removed by cystoscopy without any complications.&lt;br /&gt;
Conclusion: The mislocation of an IUD in the bladder, while uncommon, is a possibility that should be considered when the IUD string is not visible during examinations.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>238</FPAGE>
            <TPAGE>242</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Seyedeh Azam</Name>
<MidName>SA</MidName>
<Family>Pourhoseini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Leili</Name>
<MidName>L</MidName>
<Family>Hafizi</Family>
<NameE>لیلی</NameE>
<MidNameE></MidNameE>
<FamilyE>حفیظی</FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mona</Name>
<MidName>M</MidName>
<Family>Jafari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>JafariM4001@mums.ac.ir</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Contraceptive agents</KeyText></KEYWORD><KEYWORD><KeyText>Contraceptive devices</KeyText></KEYWORD><KEYWORD><KeyText>Intrauterine device</KeyText></KEYWORD><KEYWORD><KeyText>IUD migration</KeyText></KEYWORD><KEYWORD><KeyText>Uterine perforation</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140237.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Nouioui MA, Taktak T, Mokadem S, Mediouni H, Khiari R, Ghozzi S. A mislocated intrauterine device migrating to the urinary bladder: an uncommon complication leading to stone formation. Case Rep Urol. 2020;2020:2091915.##Par&#233; AK, Ouattara A, Y&#233; D, Kabr&#233; B, Bako A, Abubakar B, et al. Management of intrauterine device migrated into the bladder: a case report and literature review. Case Rep Urol. 2020;2020:8850087.##Mona A, Tardif D, Fawzy A, Socolov RV. Management of an intrauterine device migration resulting in a pregnancy–clinical case. Maedica (Bucur). 2020;15(4):549-51.##Rasekhjahromi A, Chitsazi Z, Khlili A, Babaarabi ZZ. Complications associated with intravesical migration of an intrauterine device. Obstet Gynecol Sci. 2020;63(5):675-8.##Aydogdu O, Pulat H. Asymptomatic far-migration of an intrauterine device into the abdominal cavity: a rare entity. Can Urol Assoc J. 2012;6(3):E134-6.##Sano M, Nemoto K, Miura T, Suzuki Y. Endoscopic treatment of intrauterine device migration into the bladder with stone formation. J Endourol Case Rep. 2017;3(1):105-7.##Azandaryani AR, Ghaderzadeh P, Farsangi LE. Intravesical migration of intrauterine device and calculi formation 12 years post missing: a case report. Case Rep Clin Med. 2017;6(1):24-30.##Christodoulides AP, Karaolides T. Intravesical migration of an intrauterine device (IUD)-case report. Urology. 2020;139:14-7.##Zhang P, Wang T, Yang L. Extensive intravesical benign hyperplasia induced by an extravesical migrated intrauterine device: a case report. Medicine (Baltimore). 2019;98(20):e15671.##Raj A, Xiaolei S, Wenjing X, Renfu C, Yunpeng P. A sandwich technique for the removal of stone embedded intrauterine devices in the urinary bladder. Urol Case Rep. 2021;38:101599.##Chakir Y, Daghdagh Y, Moataz A, Dakir M, Debbagh A, Aboutaieb R. Intra uterine device migrating into the bladder with stone formation. Urol Case Rep. 2021;40:101918.##Cheung ML, Rezai S, Jackman JM, Patel ND, Bernaba BZ, Hakimian O, et al. Retained intrauterine device (IUD): triple case report and review of the literature. Case Rep Obstet Gynecol. 2018;2018:9362962.##Verstraeten V, Vossaert K, Van den Bosch T. Migration of intra-uterine devices. Open Access J Contracept. 2024;15:41-7.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

    </ARTICLES>
  </JOURNAL>
</XML>
